Winnergy Medical Public Company Limited (WINMED) visited NanoEnTek, Inc. in Seoul, South Korea, from 16–17 September 2026 to explore and exchange in-depth knowledge on Biotechnology and In Vitro Diagnostics (IVD) technologies.

During the visit, the WINMED team was warmly welcomed by Mr. Chanil Chung, CEO of NanoEnTek, together with the Regional Sales Managers. The NanoEnTek team shared valuable insights into its products, technologies, and innovation development processes.

The knowledge exchange enhanced WINMED’s understanding of product features and applications, as well as the evolving direction of Biotechnology and IVD technologies. The knowledge gained can be applied to WINMED’s operations and shared with teams in Thailand to enhance the effectiveness of product information, user support, and customer services.

The visit also provided an opportunity for the WINMED team to learn directly from technology developers and gain broader perspectives on products, development processes, and approaches to addressing user needs. These insights will be valuable in applying the knowledge gained effectively to WINMED’s operations and services.

WINMED would like to express its appreciation to NanoEnTek, Inc. for the warm hospitality and for sharing valuable knowledge and experience throughout the visit. WINMED looks forward to continuing the collaboration through ongoing knowledge exchange and capability development in medical technology.